IMMUNOGENICITY
Clinical trials for IMMUNOGENICITY explained in plain language.
Never miss a new study
Get alerted when new IMMUNOGENICITY trials appear
Sign up with your email to follow new studies for IMMUNOGENICITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Mpox vaccine trial for pregnant women launches in congo
⭐️ VACCINE ⭐️ OngoingThis study tests the safety and immune response of the MVA-BN mpox vaccine in 359 pregnant and postpartum women in the Democratic Republic of the Congo. Some women receive the vaccine during pregnancy, others right after giving birth, and a small group gets it as an emergency sho…
Matched conditions: IMMUNOGENICITY
Phase: PHASE3 • Sponsor: Jean-Pierre Van geertruyden • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 15, 2026 19:05 UTC
-
Mpox vaccine trial for babies launches in congo: could half a dose be enough?
⭐️ VACCINE ⭐️ OngoingThis study tests the safety and immune response of the MVA-BN mpox vaccine in 344 infants and children aged 4 to 24 months in the Democratic Republic of the Congo. Half the children receive the standard vaccine dose, and the other half receive a half dose. The goal is to find the…
Matched conditions: IMMUNOGENICITY
Phase: PHASE3 • Sponsor: Jean-Pierre Van geertruyden • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 08, 2026 13:17 UTC
-
BREATH study: tracking biologic drug effects in severe asthma
Knowledge-focused OngoingThis study watches 100 people with severe asthma who are taking biologic drugs. Researchers measure how the body reacts to the drug and whether it affects asthma attacks. The goal is to learn more about drug effectiveness and safety.
Matched conditions: IMMUNOGENICITY
Sponsor: Samsung Medical Center • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:52 UTC